“Treat-to-Target Outcomes and Measures of Treatment Success in Three Phase 3 Trials of Tapinarof Cream 1% Once Daily for Mild to Severe Plaque Psoriasis”, J of Skin, vol. 7, no. 2, p. s124, Mar. 2023, doi: 10.25251/skin.7.supp.124.